|
1
|
Everett E and Mathioudakis N: Update on
management of diabetic foot ulcers. Ann NY Acad Sci. 1411:153–165.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Babaei V, Afradi H, Gohardani HZ, Nasseri
F, Azarafza M and Teimourian S: Management of chronic diabetic foot
ulcers using platelet-rich plasma. J Wound Care. 26:784–787. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dinh T, Tecilazich F, Kafanas A, Doupis J,
Gnardellis C, Leal E, Tellechea A, Pradhan L, Lyons TE, Giurini JM
and Veves A: Mechanisms involved in the development and healing of
diabetic foot ulceration. Diabetes. 61:2937–2947. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Demidova-Rice TN, Hamblin MR and Herman
IM: Acute and impaired wound healing: Pathophysiology and current
methods for drug delivery, part 2: Role of growth factors in normal
and pathological wound healing: Therapeutic potential and methods
of delivery. Adv Skin Wound Care. 25:349–370. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sridharan K and Sivaramakrishnan G: Growth
factors for diabetic foot ulcers: Mixed treatment comparison
analysis of randomized clinical trials. Br J Clin Pharmacol.
84:434–444. 2017. View Article : Google Scholar
|
|
6
|
Laiva AL, O'Brien FJ and Keogh MB:
Innovations in gene and growth factor delivery systems for diabetic
wound healing. J Tissue Eng Regen Med. May 8–2017.(Epub ahead of
print). PubMed/NCBI
|
|
7
|
Stern MP, Valdez RA, Haffner SM, Mitchell
BD and Hazuda HP: Stability over time of modern diagnostic criteria
for type II diabetes. Diabetes Care. 16:978–983. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wagner FW: Transcutaneous Doppler
ultrasound in the prediction of healing and the selection of
surgical level for dysvascular lesions of the toes and forefoot.
Clin Orthop Relat Res. 142:110–114. 1979.
|
|
9
|
Al-Rubeaan K, Al Derwish M, Ouizi S,
Youssef AM, Subhani SN, Ibrahim HM and Alamri BN: Diabetic foot
complications and their risk factors from a large retrospective
cohort study. PLoS One. 10:e01244462015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Naz I, Walters E, Akbari CM, Attinger CE
and Kim PJ: Noninvasive vascular assessment of lower extremity
wounds in diabetics: Are we able to predict perfusion deficits?
Surg Technol Int. 31:66–74. 2017.PubMed/NCBI
|
|
11
|
Gope ML and Gope R: Tyrosine
phosphorylation of EGF-R and PDGF-R proteins during acute cutaneous
wound healing process in mice. Wound Repair Regen. 17:71–79. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pastore S, Mascia F, Mariani V and
Girolomoni G: The epidermal growth factor receptor system in skin
repair and inflammation. J Invest Dermatol. 128:1365–1374. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schumacher B, Pecher P, Von Specht BU and
Stegmann T: Induction of neoangiogenesis in ischemic myocardium by
human growth factors: First clinical results of a new treatment of
coronary heart disease. Circulation. 97:645–650. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Simons M, Annex BH, Laham RJ, Kleiman N,
Henry T, Dauerman H, Udelson JE, Gervino EV, Pike M, Whitehouse MJ,
et al: Pharmacological treatment of coronary artery disease with
recombinant fibroblast growth factor-2: Double-blind, randomized,
controlled clinical trial. Circulation. 105:788–793. 2012.
View Article : Google Scholar
|
|
15
|
Eppler SM, Combs DL, Henry TD, Lopez JJ,
Ellis SG, Yi JH, Annex BH, Mccluskey ER and Zioncheck TF: A
target-mediated model to describe the pharmacokinetics and
hemodynamic effects of recombinant human vascular endothelial
growth factor in humans. Clin Pharmacol Ther. 72:20–32. 2013.
View Article : Google Scholar
|
|
16
|
Richardson TP, Peters MC, Ennett AB and
Mooney DJ: Polymeric system for dual growth factor delivery. Nat
Biotechnol. 19:1029–1034. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen RR, Silva EA, Yuen WW, Brock AA,
Fischbach C, Lin AS, Guldberg RE and Mooney DJ: Integrated approach
to designing growth factor delivery systems. FASEB J. 21:3896–3903.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Marui A, Kanematsu A, Yamahara K, Doi K,
Kushibiki T, Yamamoto M, Itoh H, Ikeda T, Tabata Y and Komeda M:
Simultaneous application of basic fibroblast growth factor and
hepatocyte growth factor to enhance the blood vessels formation. J
Vasc Surg. 41:82–90. 2015. View Article : Google Scholar
|
|
19
|
Ghiasi Z, Gray T, Tran P, Dubielzig R,
Murphy C, McCartney DL and Reid TW: The effect of topical
Substance-P plus insulin-like growth factor-1 (IGF-1) on epithelial
healing after photorefractive keratectomy in rabbits. Transl Vis
Sci Technol. 7:122018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
An Y, Liu WJ, Xue P, Ma Y, Zhang LQ, Zhu
B, Qi M, Li LY, Zhang YJ, Wang QT and Jin Y: Autophagy promotes
MSC-mediated vascularization in cutaneous wound healing via
regulation of VEGF secretion. Cell Death Dis. 9:582018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Saijo H, Kilpadi DV and Akita S:
Evaluation of the use of recombinant human basic fibroblast growth
factor in combination with negative pressure wound therapy with
instillation and dwell time in porcine full-thickness wound model.
Wound Repair Regen. Jan 12–2018.(Epub ahead of print).
|
|
22
|
Simmons CA, Alsberg E, Hsiong S, Kim WJ
and Mooney DJ: Dual growth factor delivery and controlled scaffold
degradation enhance in vivo bone formation by transplanted bone
marrow stromal cells. Bone. 35:562–569. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Basmanav FB, Kose GT and Hasirci V:
Sequential growth factor delivery from complexed microspheres for
bone tissue engineering. Biomaterials. 29:4195–4204. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Patel ZS, Young S, Tabata Y, Jansen JA,
Wong ME and Mikos AG: Dual delivery of an angiogenic and an
osteogenic growth factor for bone regeneration in a critical size
defect model. Bone. 43:931–940. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hutchings H, Ortega N and Plouet J:
Extracellular matrix-bound vascular endothelial growth factor
promotes endothelial cell adhesion, migration, and survival through
integrin ligation. FASEB J. 17:1520–1522. 2013. View Article : Google Scholar
|
|
26
|
Tsou R and Isik FF: Integrin activation is
required for VEGF and FGF receptor protein presence on human
microvascular endothelial cells. Mol Cell Biochem. 224:81–89. 2011.
View Article : Google Scholar
|
|
27
|
Li B, Davidson JM and Guelcher SA: The
effect of the local delivery of platelet-derived growth factor from
reactive two-component polyurethane scaffolds on the healing in rat
skin excisional wounds. Biomaterials. 30:3486–3494. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Silva AK, Richard C, Bessodes M, Scherman
D and Merten OW: Growth factor delivery approaches in hydrogels.
Biomacromolecules. 10:9–18. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sakiyama-Elbert SE and Hubbell JA:
Development of fibrin derivatives for controlled release of
heparin-binding growth factors. J Control Release. 65:389–402.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang X, Ding X, Lin X, Yang P and Lin K:
Clinical observation of recombinant human epidermal growth factor
combined with lipoic acid in the treatment of diabetic foot. Chin
Pharm. 27:4147–4149. 2016.(In Chinese).
|
|
31
|
Johnson NR and Wang Y: Controlled delivery
of heparin-binding EGF-like growth factor yields fast and
comprehensive wound healing. J Control Release. 166:124–129. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bae IH, Park JW and Kim DY: Enhanced
regenerative healing efficacy of a highly skin-permeable growth
factor nanocomplex in a full-thickness excisional mouse wound
model. Int J Nanomedicine. 9:4551–4567. 2014.PubMed/NCBI
|
|
33
|
Loot MA, Kenter SB, Au FL, van Galen WJ,
Middelkoop E, Bos JD and Mekkes JR: Fibroblasts derived from
chronic diabetic ulcers differ in their response to stimulation
with EGF, IGF-I, bFGF and PDGF-AB compared to controls. Eur J Cell
Biol. 81:153–160. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nie K, Li P, Zeng X, Sun G, Jin W, Wei Z,
Wang B, Qi J, Wang Y and Wang D: Clinical observation of basic
fibroblast growth factor combined with topical oxygen therapy in
enhancing burn wound healing. Chin J Rep Rec Surg. 6:643–646.
2010.(In Chinese).
|
|
35
|
Tiaka EK, Papanas N, Manolakis AC and
Maltezos E: The role of nerve growth factor in the prophylaxis and
treatment of diabetic foot ulcers. Int J Burns Trauma. 1:68–76.
2011.PubMed/NCBI
|
|
36
|
Sheridan MH, Shea LD, Peters MC and Mooney
DJ: Bioabsorbable polymer scaffolds for tissue engineering capable
of sustained growth factor delivery. J Control Release. 64:91–102.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Chen RR and Mooney DJ: Polymeric growth
factor delivery strategies for tissue engineering. Pharm Res.
20:1103–1112. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhu XH, Wang CH and Tong YW: In vitro
characterization of hepatocyte growth factor release from PHBV/PLGA
microsphere scaffold. J Biomed Mater Res A. 89:411–423. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pepper MS, Ferrara N, Orci L and Montesano
R: Potent synergism between vascular endothelial growth factor and
basic fibroblast growth factor in the induction of angiogenesis in
vitro. Biochem Biophys Res Commun. 189:824–831. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hamann Jimenez MC, Tator CH and Shoichet
MS: Injectable intrathecal delivery system for localized
administration of EGF and FGF-2 to the injured rat spinal cord. Exp
Neurol. 194:106–119. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yang HS, Shin J, Bhang SH, Shin JY, Park
J, Im GI, Kim CS and Kim BS: Enhanced skin wound healing by a
sustained release of growth factors contained in platelet-rich
plasma. Exp Mol Med. 43:622–629. 2011. View Article : Google Scholar : PubMed/NCBI
|
